Jessica Fye
Stock Analyst at J.P. Morgan
(3.91)
# 1,755
Out of 5,043 analysts
604
Total ratings
51.2%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Reiterated: Hold | $35 → $33 | $18.62 | +77.23% | 14 | Oct 9, 2026 | |
| HALO Halozyme Therapeutics | Rated: Hold | $65 → $78 | $110.42 | -29.36% | 20 | Oct 8, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $687 → $710 | $549.16 | +29.29% | 35 | Oct 8, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $425 → $445 | $354.47 | +25.54% | 15 | Oct 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Rated: Buy | $375 → $369 | $232.68 | +58.59% | 29 | Sep 30, 2026 | |
| BCRX BioCryst Pharmaceuticals | Rated: Hold | $12 → $13 | $8.55 | +52.05% | 20 | Sep 30, 2026 | |
| INCY Incyte | Reiterated: Hold | $120 → $123 | $112.79 | +9.05% | 27 | Sep 28, 2026 | |
| INSM Insmed | Reiterated: Buy | $175 | $100.60 | +73.96% | 29 | Sep 28, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | n/a | $86.01 | - | 16 | Sep 28, 2026 | |
| MRNA Moderna | Reiterated: Sell | n/a | $225.00 | - | 25 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 → $70 | $45.28 | +54.59% | 34 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $40.61 | - | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $54.80 | +56.95% | 17 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $229.23 | - | 51 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $530 → $560 | $510.08 | +9.79% | 22 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $10 → $13 | $12.03 | +8.06% | 11 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $7.06 | - | 14 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $29.39 | +70.13% | 15 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $88 | $53.24 | +65.29% | 4 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $65 | $41.17 | +57.88% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 → $40 | $24.74 | +61.68% | 18 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $96.96 | - | 32 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $18.15 | +81.82% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $19.45 | +49.10% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $276 | $218.42 | +26.36% | 34 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $17 | $14.58 | +16.60% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.19 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $14 | $25.79 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $1.68 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $19 | $1.03 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.6044 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $82.37 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 → $66 | $144.82 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $12.75 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $12.50 | n/a | 4 | Feb 8, 2018 |
Legend Biotech
Oct 9, 2026
Reiterated: Hold
Price Target: $35 → $33
Current: $18.62
Upside: +77.23%
Halozyme Therapeutics
Oct 8, 2026
Rated: Hold
Price Target: $65 → $78
Current: $110.42
Upside: -29.36%
United Therapeutics
Oct 8, 2026
Reiterated: Buy
Price Target: $687 → $710
Current: $549.16
Upside: +29.29%
BeOne Medicines AG
Oct 1, 2026
Reiterated: Buy
Price Target: $425 → $445
Current: $354.47
Upside: +25.54%
Alnylam Pharmaceuticals
Sep 30, 2026
Rated: Buy
Price Target: $375 → $369
Current: $232.68
Upside: +58.59%
BioCryst Pharmaceuticals
Sep 30, 2026
Rated: Hold
Price Target: $12 → $13
Current: $8.55
Upside: +52.05%
Incyte
Sep 28, 2026
Reiterated: Hold
Price Target: $120 → $123
Current: $112.79
Upside: +9.05%
Insmed
Sep 28, 2026
Reiterated: Buy
Price Target: $175
Current: $100.60
Upside: +73.96%
Mirum Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $86.01
Upside: -
Moderna
Sep 28, 2026
Reiterated: Sell
Price Target: n/a
Current: $225.00
Upside: -
Sep 22, 2026
Rated: Buy
Price Target: $76 → $70
Current: $45.28
Upside: +54.59%
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $40.61
Upside: -
Sep 21, 2026
Reiterated: Buy
Price Target: $86
Current: $54.80
Upside: +56.95%
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $229.23
Upside: -
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $530 → $560
Current: $510.08
Upside: +9.79%
Aug 21, 2026
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $12.03
Upside: +8.06%
Aug 21, 2026
Initiated Coverage: Sell
Price Target: n/a
Current: $7.06
Upside: -
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $29.39
Upside: +70.13%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $53.24
Upside: +65.29%
Aug 21, 2026
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $41.17
Upside: +57.88%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $24.74
Upside: +61.68%
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $96.96
Upside: -
Aug 14, 2026
Rated: Buy
Price Target: $33
Current: $18.15
Upside: +81.82%
Aug 11, 2026
Reiterated: Buy
Price Target: $29
Current: $19.45
Upside: +49.10%
Aug 4, 2026
Rated: Buy
Price Target: $276
Current: $218.42
Upside: +26.36%
Jul 13, 2026
Reiterated: Hold
Price Target: $23 → $17
Current: $14.58
Upside: +16.60%
Oct 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $42.19
Upside: -
Jun 7, 2022
Reiterated: Hold
Price Target: $18 → $14
Current: $25.79
Upside: n/a
Apr 7, 2022
Reiterated: Hold
Price Target: $7 → $5
Current: $1.68
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $20 → $19
Current: $1.03
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.6044
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $82.37
Upside: n/a
Apr 6, 2020
Reiterated: Hold
Price Target: $94 → $66
Current: $144.82
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $12.75
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $12.50
Upside: n/a